Skip to main content

ADVERTISEMENT

Daniel G. Clair, MD

02/24/2019
Our objective was to investigate the efficacy and safety of LimFlow percutaneous deep vein arterialization device in no-option CLI patients.
Our objective was to investigate the efficacy and safety of LimFlow percutaneous deep vein arterialization device in no-option CLI patients.
Our objective was to investigate...
02/24/2019
Journal of Invasive Cardiology
FDA Panel
07/31/2019
Since a large portion of my practice consists of patients with complex lesions, I have continued to use these devices extensively and will plan to continue using them as I currently do.
Since a large portion of my practice consists of patients with complex lesions, I have continued to use these devices extensively and will plan to continue using them as I currently do.
Since a large portion of my...
07/31/2019
Cath Lab Digest
FDA Panel
06/20/2019
VDM talks with Daniel Clair, MD, Chair of Surgery, Palmetto Health/USC Medical Group, Columbia, South Carolina, regarding the FDA panel meeting that took place June 19th-20th, and his thoughts on drug-coated balloon use.
VDM talks with Daniel Clair, MD, Chair of Surgery, Palmetto Health/USC Medical Group, Columbia, South Carolina, regarding the FDA panel meeting that took place June 19th-20th, and his thoughts on drug-coated balloon use.
VDM talks with Daniel Clair, MD,...
06/20/2019
Vascular Disease Management
Interview
03/09/2020
VDM spoke with Daniel Clair, MD, to discuss the impact of new technologies for aortic aneurysm therapy on the field and which patients are best suited for open abdominal aortic aneurysm repair.
VDM spoke with Daniel Clair, MD, to discuss the impact of new technologies for aortic aneurysm therapy on the field and which patients are best suited for open abdominal aortic aneurysm repair.
VDM spoke with Daniel Clair, MD,...
03/09/2020
Vascular Disease Management
Dr Daniel Clair
ISET 2023
02/23/2023
In this video from ISET 2023, Dr. Daniel Clair from Vanderbilt University Medical Center in Nashville, Tennessee, discusses his presentations on endograft durability and results of the PROMISE II trial.
In this video from ISET 2023, Dr. Daniel Clair from Vanderbilt University Medical Center in Nashville, Tennessee, discusses his presentations on endograft durability and results of the PROMISE II trial.
In this video from ISET 2023,...
02/23/2023
Vascular Disease Management
Interview
12/21/2023
VDM spoke with Dr. Clair to discuss the registry results and what they mean for patients with critical limb-threatening ischemia (CLTI).
VDM spoke with Dr. Clair to discuss the registry results and what they mean for patients with critical limb-threatening ischemia (CLTI).
VDM spoke with Dr. Clair to...
12/21/2023
Vascular Disease Management